Key facts
- Magvation’s last known valuation is $64.0M (Nov 2023).
- It has raised $18.5M across 2 recorded rounds; the latest was Early Stage VC ($5.5M) in Sep 2025.
- Notable investors include Vest Coast Capital.
- Magvation has filed 2 Form Ds with the SEC since 2024, most recently Jun 2025 ($8.8M sold to 119 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Magvation
Funding rounds
2 roundsAbout Magvation
Developer of an AI-powered collaborative robot designed to reduce preventable error-causing factors in the operating room. The company offers a surgical safety system and a mobile surgical platform to simplify and streamline operating room processes, help facilitate repeatable and predictable safety measures, and allow efficient and effective surgeries, enabling the healthcare industry to focus on more demanding and productive tasks while reducing human errors.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Founded
- 2016
- Employees
- 15
- Website
- magvation.com/
- Ownership
- Privately Held (backing)
Magvation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Magvation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Magvation in its N-PORT filings yet. We sweep new filings monthly.